Ecolab's fourth quarter earnings showed sequential improvement from the third quarter despite the negative impact from the greater than expected COVID-19 second wave. Reported sales from continuing operations decreased by 6% from the year-ago period. Adjusted diluted EPS from continuing operations were $1.23, a decrease of 15% versus last year.
Fourth quarter earnings showed sequential improvement from the third quarter despite the negative impact from the greater than expected COVID-19 second wave.
Reported sales from continuing operations decreased 6% from the year-ago period.
Reported diluted EPS from continuing operations was $1.04, a decrease of 23% versus last year.
Adjusted diluted EPS from continuing operations were $1.23, a decrease of 15% versus last year, reflecting COVID-19 related volume declines, unfavorable business mix and investments in the business which together more than offset cost savings, favorable pricing and lower variable compensation.
Ecolab expects COVID-19 will continue to have a significant effect on the economy and its end markets, with its primary impact in the early part of the year. The company expects to see the beginning of the COVID-19 recovery in its global end markets starting in the second quarter but believes it will take several quarters to fully realize a new normal.
Visualization of income flow from segment revenue to net income